iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 100.00K | 200.00K | -- | 200.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 100.00K | 200.00K | -- | 200.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 100.00K | 200.00K | -- | 200.00K |
| SG&A Expenses | 5.17M | 2.50M | 2.17M | 2.97M | 2.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.45M | 6.05M | 5.40M | 4.88M | 4.62M |
| Operating Income | -9.45M | -5.95M | -5.20M | -4.88M | -4.42M |
| Income Before Tax | -8.99M | -5.72M | -5.16M | -4.86M | -4.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.99M | -5.72M | -5.16M | -4.86M | -4.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.99M | -5.72M | -5.16M | -4.86M | -4.36M |
| EBIT | -9.45M | -5.95M | -5.20M | -4.88M | -4.42M |
| EBITDA | -9.30M | -5.76M | -5.00M | -4.69M | -4.22M |
| EPS Basic | -0.09 | -0.29 | -0.36 | -0.49 | -0.48 |
| Normalized Basic EPS | -0.06 | -0.18 | -0.22 | -0.31 | -0.30 |
| EPS Diluted | -0.09 | -0.29 | -0.36 | -0.49 | -0.48 |
| Normalized Diluted EPS | -0.06 | -0.18 | -0.22 | -0.31 | -0.30 |
| Average Basic Shares Outstanding | 99.13M | 19.67M | 14.39M | 9.86M | 9.13M |
| Average Diluted Shares Outstanding | 99.13M | 19.67M | 14.39M | 9.86M | 9.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |